Arcturus Therapeutics Holdings Inc.
ARCT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $458,190 | $839,581 | $448,507 | $973,992 |
| - Cash | $237,028 | $292,005 | $391,883 | $370,492 |
| + Debt | $28,550 | $30,216 | $94,755 | $69,146 |
| Enterprise Value | $249,712 | $577,792 | $151,379 | $672,646 |
| Revenue | $138,389 | $157,748 | $205,755 | $12,359 |
| % Growth | -12.3% | -23.3% | 1,564.8% | – |
| Gross Profit | $138,389 | $157,748 | $205,755 | $12,359 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$77,401 | -$24,165 | $13,704 | -$201,659 |
| % Margin | -55.9% | -15.3% | 6.7% | -1,631.7% |
| Net Income | -$80,941 | -$29,725 | $9,349 | -$203,674 |
| % Margin | -58.5% | -18.8% | 4.5% | -1,648% |
| EPS Diluted | -3 | -1.12 | 0.35 | -7.74 |
| % Growth | -167.9% | -420% | 104.5% | – |
| Operating Cash Flow | -$59,747 | -$18,099 | $31,993 | -$135,043 |
| Capital Expenditures | -$648 | -$2,901 | -$7,726 | -$3,406 |
| Free Cash Flow | -$60,395 | -$21,000 | $24,267 | -$138,449 |